Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

RICHMOND, Va.,--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA TO HOST WEBCAST OF 2021 ANNUAL MEETING OF SHAREHOLDERS

Altria to Host Webcast of 2021 Annual Meeting of Shareholders

Many investors dream of making a fortune in the stock market, and ensuring a comfortable retirement. It doesn't take genius, just disciplined financial science.

3 Reasons Altria Is Set To Soar And Too Cheap To Ignore

ASGN

Growth stocks upped the markets, with Apple, Tesla, Amazon, Alphabet, and Microsoft rising after yesterday's sell-off. Make the most of this market with today's top buys from Q.ai's artificial intelligence systems.

Asgn Inc (ASGN) And Altria Group Inc (MO) Among Today's Top Buys

Atlantica Sustainable Infrastructure

Con Ed

Eaton Vance Tax-Managed Global Diversified Equity Income Fund

ONEOK

Old Republic International

Global X NASDAQ 100 Covered Call ETF

Southern Company

Starwood Property

AT&T

Exxon Mobil

After 9 weeks and $900, the Dividend Harvesting Portfolio is generating $55.66 in estimated annual income and $4.64 in monthly estimated income. In week 9, I added Consolidated Edison and an additional share of AT&T to the Dividend Harvesting Portfolio.

Dividend Harvesting: Building The Portfolio Brick By Brick On $100 A Week, Week 9 Update

T. Rowe Price Group

30% earnings growth, the end of the pandemic in the US, and record-smashing stimulus is causing the market to roar higher. The S&P 500 is 36% overvalued. It's a market of stocks, not a stock market, and wonderful blue-chips for any need are always available.

The 2 Safest Dividend Aristocrats You Can Buy With The Market At All-Time Highs

ARK Innovation ETF

Bristol-Myers

Enterprise Products Partners

Lockheed Martin

Omega Healthcare Investors

Philip Morris

Invesco QQQ

SPDR S&P 500 ETF Trust

Markets have been running to new all-time highs, but there are some risk factors that investors should keep in mind. Moving to cash isn't a great choice, due to rising inflationary pressures.

5 Undervalued Income Stocks That Offer Stability In Uncertain Times

AbbVie

Anheuser-Busch InBev

GEO Group

NRG Energy

Nintendo

Sunoco

Although growth-related investments have been all the rage, smart investors should see the potential in buying value stocks. The post 7 Value Stocks You Want In Your Life appeared first on InvestorPlace.

7 Value Stocks You Want In Your Life

British American Tobacco

Imperial Brands PLC

The U.S. Food and Drug Administration (FDA) on Thursday agreed to a petition from more than a dozen public health and civil rights groups that could lead to a ban on menthol cigarettes and flavored cigars by next year.

FDA Proposes Ban on Menthol Cigarettes, Flavored Cigars

Altria shares are trading at a 7% Dividend Yield and an 11x P/E after falling 11% from their mid-April peak, even with solid Q1 results. Smokeable volume fell 12% in Q1 due to prior-year COVID-related stocking up, but strong pricing meant EPS was down only 1.7%.

Altria: On Sale Again After Q1 With 7% Dividend Yield And 11x P/E

Arbor Realty Trust

Cheniere Energy Partners

Capital Southwest

Diamond Hill Investment Group

Delek Logistics Partners

Enbridge

Enviva Partners

Hess Midstream Partners

MGM Growth Properties

W. P. Carey

High yield stocks carry more risk and are higher maintenance than core dividend growth companies, but there are ways to safely incorporate them into a portfolio. High-yield positions will provide a disproportionate amount of income relative to the position size.

How Does High Yield Fit Into A DGI Portfolio - Bucket Investing Part 2

Altria Group, Inc. (MO) CEO Billy Gifford on Q1 2021 Results - Earnings Call Transcript

US health regulators have announced plans to ban menthol cigarettes — but critics argue it could fuel a dangerous black market for the flavored smokes.

FDA announces plans to ban menthol cigarettes

Altria's (MO) first-quarter performance is hurt by soft cigarette shipment volumes. Nevertheless, higher pricing continue to remain an upside.

Altria (MO) Q1 Earnings Beat Estimates, Revenues Down Y/Y

The announcement marked the launch of a federal rule-making process that could take years and face challenges from the tobacco industry.

FDA Proposes Menthol Cigarette Ban

The ban would hit certain tobacco companies harder than others.

FDA Moves to Ban Menthol Cigarettes

The U.S. Food and Drug Administration announced Thursday that it will propose a ban on menthol-flavored cigarettes in the United States.

FDA to propose ban on menthol-flavored cigarettes

The U.S. Food and Drug Administration on Thursday proposed a ban on menthol cigarettes in the United States, a win for anti-tobacco and civil rights groups, but a move that could erase a huge chunk of sales for cigarette manufacturers.

U.S. FDA proposes ban on menthol cigarettes

Altria (MO) delivered earnings and revenue surprises of 2.88% and -2.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Q1 Earnings Surpass Estimates

Altria first-quarter earnings declined as revenue fell short of estimates as cigarette shipments continue to decline.

Marlboro parent Altria revenue falls short as cigarette shipments decline, buys rest of On nicotine pouch

Shares of Altria Group (NYSE:MO) moved higher by 0.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 1.83% over the past year to $1.07, which beat the estimate of $1.05.

Recap: Altria Group Q1 Earnings

Altria Group Inc. said Thursday it had net income of $1.424 billion, or 77 cents a share, in the first quarter, down from $1.552 billion, or 83 cents a share, in the year-earlier period. Adjusted per-share earnings came to $1.07, ahead of the $1.05 FactSet consensus.

Altria profit beats as revenue falls short and company sticks with full-year guidance

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ACQUIRES--ALTRIA REPORTS 2021 FIRST-QUARTER RESULTS; REAFFIRMS 2021 EARNINGS GUIDANCE; ACQUIRES REMAINING 20% OF GLOBAL on! BUSINESS

Altria Reports 2021 First-Quarter Results; Reaffirms 2021 Earnings Guidance; Acquires Remaining 20% of Global on! Business

Altria stock (NYSE: MO) dropped more than 9% in just the last one week (five trading days) and currently trades at $47 per share. MO stock dropped after news reports came out saying the Joe Biden administration is considering new restrictions on tobacco products sold in the U.S. Sources claimed.

How U.S. Government Tobacco Restrictions Drove A Slide In Altria Stock

Caterpillar

McDonald's

Merck

A quick glance at the calendar for this week shows some 900 publicly traded companies are scheduled to report March quarter earnings this week.

Earnings Previews: Altria, Caterpillar, McDonald's, Merck

Cloudera

Editas Medicine

KraneShares CSI China Internet ETF

Roku

VanEck Low Carbon Energy ETF

Tencent Music Entertainment Group 

Broader markets be at all-time highs, but there are still opportunities for the coming months. Here are seven stocks to buy this May.

7 Stocks to Buy for May

News for Altria Stock (MO)